FDA-AstraZeneca Hearing
Conflicts for FDA committee set to weigh risks of Seroquel_Philadelphia Inquirer
FDA officials who continue to run its powerful center for drug evaluation (CDER) have once again shown bad faith by appointing financially compromised doctors to the Psychopharmacologic Drugs Advisory Committee (PDAC) advisory panel.